Found: 69
Select item for more details and to access through your institution.
Thrombosis, cancer and renal insufficiency: low molecular weight heparin at the crossroads.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 12, p. 3033, doi. 10.1007/s00520-012-1590-9
- By:
- Publication type:
- Article
Dalteparin anticoagulation in paediatric home haemodialysis.
- Published in:
- Pediatric Nephrology, 2018, v. 33, n. 12, p. 2337, doi. 10.1007/s00467-018-4032-1
- By:
- Publication type:
- Article
Increased Urine IgMand IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.
- Published in:
- Biotechnology Research International, 2012, p. 1, doi. 10.1155/2012/480529
- By:
- Publication type:
- Article
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis.
- Published in:
- Intensive Care Medicine, 2013, v. 39, n. 12, p. 2135, doi. 10.1007/s00134-013-3044-3
- By:
- Publication type:
- Article
The Impact of Small Bowel Endoscopy in Patients with Hereditary Hemorrhagic Telangiectasia.
- Published in:
- Turkish Journal of Hematology, 2018, v. 35, n. 4, p. 300, doi. 10.4274/tjh.2018.0253
- By:
- Publication type:
- Article
Effect of low-molecular-weight heparins on anti-Xa peak levels and adverse reactions in Chinese patients with recurrent spontaneous abortion: a single-center, observational study.
- Published in:
- BMC Pregnancy & Childbirth, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12884-021-04161-1
- By:
- Publication type:
- Article
Role of dalteparin sodium on the growth of cancer cells and tumor-associated angiogenesis in A549 human lung cancer cell line and grafted mouse model.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Complexity of Venous Thromboembolism Risk in the Medically Ill Population.
- Published in:
- Current Medical Literature: Lysosomal Storage Disease, 2012, v. 10, n. 1, p. 81
- Publication type:
- Article
Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies.
- Published in:
- Molecules, 2017, v. 22, n. 7, p. 1051, doi. 10.3390/molecules22071051
- By:
- Publication type:
- Article
Session 03: The impact of new clinical evidence in (early) pregnancy.
- Published in:
- Human Reproduction, 2013, v. 28, n. suppl_1, p. i4, doi. 10.1093/humrep/det158
- Publication type:
- Article
External Iliac Vein Thrombosis in an Athletic Cyclist With a History of External Iliac Artery Endofibrosis and Thrombosis.
- Published in:
- Vascular & Endovascular Surgery, 2011, v. 45, n. 8, p. 761, doi. 10.1177/1538574411418841
- By:
- Publication type:
- Article
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 20, p. 2135, doi. 10.1001/jama.2014.15101
- By:
- Publication type:
- Article
Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 1, p. 68, doi. 10.1177/1078155217727140
- By:
- Publication type:
- Article
A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris.
- Published in:
- Indian Journal of Pharmacology, 2011, v. 43, n. 6, p. 703, doi. 10.4103/0253-7613.89830
- By:
- Publication type:
- Article
Thromboembolism prophylaxis with dabigatran leads to lower perioperative blood loss than with dalteparin in primary knee arthroplasty.
- Published in:
- Archives of Orthopaedic & Trauma Surgery, 2011, v. 131, n. 12, p. 1739, doi. 10.1007/s00402-011-1335-0
- By:
- Publication type:
- Article
A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer.
- Published in:
- Respiration, 2019, v. 98, n. 3, p. 203, doi. 10.1159/000499895
- By:
- Publication type:
- Article
Clinical Experience with Ximelagatran in Orthopaedic Surgery.
- Published in:
- Drugs, 2004, v. 64, n. 1, p. 27, doi. 10.2165/00003495-200464001-00005
- By:
- Publication type:
- Article
Pulmonary thrombo-embolic disease.
- Published in:
- CME: Continuing Medical Education, 2013, v. 31, n. 9, p. 335
- By:
- Publication type:
- Article
Monitoring of low molecular weight heparin anticoagulation during haemodialysis with a Sonoclot Analyzer.
- Published in:
- Perfusion, 2010, v. 25, n. 4, p. 191, doi. 10.1177/0267659110374675
- By:
- Publication type:
- Article
Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients, with similar costs.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
Aspirin after dalteparin was noninferior to continued dalteparin for preventing VTE after total hip arthroplasty.
- Published in:
- ACP Journal Club, 2013, v. 159, n. 6, p. 11, doi. 10.7326/0003-4819-159-6-201309170-02012
- By:
- Publication type:
- Article
Increased dose primary thromboprophylaxis in ambulatory patients with advanced pancreatic ductal adenocarcinoma, a single centre cohort study.
- Published in:
- Thrombosis Journal, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12959-020-00222-1
- By:
- Publication type:
- Article
Effect of dalteparin, a low-molecular-weight heparin, as adjunctive therapy in patients with Kawasaki disease: a retrospective study.
- Published in:
- BMC Pediatrics, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2431-14-27
- By:
- Publication type:
- Article
A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 8, p. 921, doi. 10.1007/s00228-015-1880-5
- By:
- Publication type:
- Article
Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin.
- Published in:
- Journal of Veterinary Emergency & Critical Care, 2014, v. 24, n. 4, p. 421, doi. 10.1111/vec.12206
- By:
- Publication type:
- Article
Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses.
- Published in:
- Journal of Veterinary Emergency & Critical Care, 2013, v. 23, n. 3, p. 291, doi. 10.1111/vec.12049
- By:
- Publication type:
- Article
Study finds Aspirin, Dalteparin equally effective for VTE prevention.
- Published in:
- Pulse International, 2013, v. 14, n. 12, p. 15
- Publication type:
- Article
Enhanced effect of fibroblast growth factor-2-containing dalteparin/protamine nanoparticles on hair growth.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2016, v. 9, p. 127, doi. 10.2147/CCID.S108187
- By:
- Publication type:
- Article
Immediate Type Hypersensitivity to Heparins: Two Case Reports and a Review of the Literature.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2011, v. 22, n. 6, p. 615, doi. 10.1016/j.rbmo.2011.03.016
- By:
- Publication type:
- Article
Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Hypoxia and the Anticoagulants Dalteparin and Acetylsalicylic Acid Affect Human Placental Amino Acid Transport.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0099217
- By:
- Publication type:
- Article
Does dalteparin PROTECT better than heparin?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Wound problems following hip arthroplasty before and after the introduction of a direct thrombin inhibitor for thromboprophylaxis.
- Published in:
- Hip International, 2011, v. 21, n. 6, p. 678, doi. 10.5301/HIP.2011.8842
- By:
- Publication type:
- Article
Low-molecular-weight heparin for hip fracture patients treated with osteosynthesis: should thromboprophylaxis start before or after surgery? An observational study of 45,913 hip fractures reported to the Norwegian Hip Fracture Register.
- Published in:
- Acta Orthopaedica, 2018, v. 89, n. 6, p. 615, doi. 10.1080/17453674.2018.1519101
- By:
- Publication type:
- Article
Randomized Controlled Trial to Evaluate Regional Citrate Anticoagulation Plus Low-Dose of Dalteparin in Continuous Veno-Venous Hemofiltration.
- Published in:
- Blood Purification, 2015, v. 39, n. 4, p. 306, doi. 10.1159/000381662
- By:
- Publication type:
- Article
Aspirin Is as Safe and Effective as LMWH for Extended Thromboprophylaxis After Total Hip Arthroplasty.
- Published in:
- American Family Physician, 2013, v. 88, n. 11, p. 739
- By:
- Publication type:
- Article
Use of Dalteparin beyond 6 Months in Cancer Patients with VTE is Feasible.
- Published in:
- MD Conference Express, 2013, v. 13, n. 13, p. 13, doi. 10.1177/155989771313006
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 2, p. 172, doi. 10.1002/jcph.1716
- By:
- Publication type:
- Article
A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 286, doi. 10.1177/1060028020952749
- By:
- Publication type:
- Article
Time Course and the Recanalization Rate of Superficial Vein Thrombosis Treated With Low-Molecular-Weight Heparin.
- Published in:
- Angiology, 2015, v. 66, n. 4, p. 381, doi. 10.1177/0003319714533183
- By:
- Publication type:
- Article
Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss.
- Published in:
- Annals of Internal Medicine, 2015, v. 162, n. 9, p. 601, doi. 10.7326/M14-2062
- By:
- Publication type:
- Article
Aspirin after daiteparin was noninferior to continued daiteparin for preventing VTE after total hip arthroplasty.
- Published in:
- Annals of Internal Medicine, 2013, v. 159, n. 6, p. JC12, doi. 10.7326/0003-4819-159-6-201309170-02012
- By:
- Publication type:
- Article
Heparin-Induced Hyperkalemia in an Extremely-Low-Birth-Weight Infant: A Case Report.
- Published in:
- Journal of Clinical Research in Pediatric Endocrinology, 2014, v. 6, n. 2, p. 125, doi. 10.4274/jcrpe.1255
- By:
- Publication type:
- Article
Prophylactic Dose of Dalteparin in Pregnant Women With History of Venous Thromboembolisms and/or Thrombophilia: Real-World Data.
- Published in:
- Angiology, 2023, v. 74, n. 8, p. 783, doi. 10.1177/00033197221126244
- By:
- Publication type:
- Article
Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo NORRBY & NORDENHEM DALTEPARIN STIMULATES ANGIOGENESIS.
- Published in:
- APMIS, 2010, v. 118, n. 12, p. 949, doi. 10.1111/j.1600-0463.2010.02635.x
- By:
- Publication type:
- Article
Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1103, doi. 10.3390/cancers11081103
- By:
- Publication type:
- Article
Femoral nerve palsy associated with bilateral spontaneous iliopsoas haematomas: a complication of venous thromboembolism therapy.
- Published in:
- Age & Ageing, 2016, v. 45, n. 1, p. 175, doi. 10.1093/ageing/afv176
- By:
- Publication type:
- Article
Prevention and treatment of venous thromboembolism in patients with cancer.
- Published in:
- Canadian Pharmacists Journal, 2012, v. 145, n. 1, p. 24, doi. 10.3821/1913-701X-145.1.24
- By:
- Publication type:
- Article
Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.
- Published in:
- 2016
- By:
- Publication type:
- journal article